The United States is not ready to vaccinate against High Pathogenicity Avian Influenza (HPAI). According to John R. Clifford, veterinary trade policy
Original content
advisory for the USA Poultry & Egg Export Council, an approved vaccine is not yet available that is a “good match to the virus.” That leaves biosecurity measures as the best U.S. weapon against the virus. Clifford, who is scheduled to speak at the upcoming Chicken Marketing Summit, says the worst-case scenario would be the continuation of the current situation for “many years.” The Chicken Marketing Summit is scheduled for July 31 to Aug. 2 in Miramar Beach, FL. Vaccinations against HPAI are being used in Mexico, China, Egypt and Vietnam. The highly pathogenic avian influenza (HPAI) viruses have been detected in U.S. wild aquatic birds, commercial poultry, and backyard or hobbyist flocks since January 2022, causing the destruction of 58,645,211 birds. These are the first detections of HPAI viruses A (H5N1) in the U.S. since 2016. The virus is increasingly being found in mammals in the United States and other countries. Bird flu does not currently threaten food safety and only one ...
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes.
To learn more about our cookies, please read our Privacy Policy.